tiprankstipranks
Clinigence Holdings (NUTX)
NASDAQ:NUTX
US Market
NUTX
Clinigence Holdings
RESEARCH TOOLSreports
Want to see NUTX full AI Analyst Report?

Clinigence Holdings (NUTX) Ratios

408 Followers

Clinigence Holdings Ratios

NUTX's free cash flow for Q2 2026 was $0.67. For the 2026 fiscal year, NUTX's free cash flow was decreased by $ and operating cash flow was $0.58. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.00 3.41 2.08 1.56 1.79
Quick Ratio
 4.96 3.39 2.06 1.50 1.72
Cash Ratio
 1.75 1.18 0.31 0.38 0.62
Solvency Ratio
 0.44 0.18 0.16 -0.09 -1.32
Operating Cash Flow Ratio
 2.39 1.57 0.16 0.02 0.92
Short-Term Operating Cash Flow Coverage
 32.54 17.63 1.29 0.09 3.34
Net Current Asset Value
$ 128.33M$ 43.72M$ -160.95M$ -228.29M$ -213.45M
Leverage Ratios
Debt-to-Assets Ratio
 0.36 0.38 0.52 0.69 0.62
Debt-to-Equity Ratio
 0.88 1.07 2.33 4.49 2.79
Debt-to-Capital Ratio
 0.47 0.52 0.70 0.82 0.74
Long-Term Debt-to-Capital Ratio
 0.07 0.08 0.13 0.30 0.19
Financial Leverage Ratio
 2.45 2.79 4.48 6.48 4.50
Debt Service Coverage Ratio
 11.04 6.15 3.54 -0.31 -14.72
Interest Coverage Ratio
 18.42 12.40 6.55 -1.95 -32.55
Debt to Market Cap
 0.03 0.04 0.25 0.34 0.03
Interest Debt Per Share
 53.43 58.73 70.63 66.26 66.17
Net Debt to EBITDA
 0.37 0.58 2.00 -17.40 -0.59
Profitability Margins
Gross Profit Margin
51.26%50.76%40.89%14.04%7.03%
EBIT Margin
42.91%30.51%27.02%-12.99%-185.67%
EBITDA Margin
45.39%32.85%30.97%-5.89%-179.68%
Operating Profit Margin
43.02%31.49%27.22%-12.83%-185.41%
Pretax Profit Margin
40.57%27.97%22.87%-19.58%-191.36%
Net Profit Margin
21.25%8.09%10.87%-18.49%-193.70%
Continuous Operations Profit Margin
32.18%20.61%19.85%-17.53%-197.33%
Net Income Per EBT
52.38%28.92%47.54%94.42%101.22%
EBT Per EBIT
94.29%88.81%84.02%152.61%103.21%
Return on Assets (ROA)
18.65%7.71%7.96%-11.50%-98.39%
Return on Equity (ROE)
51.88%21.49%35.65%-74.51%-443.11%
Return on Capital Employed (ROCE)
42.99%36.24%25.39%-9.35%-107.88%
Return on Invested Capital (ROIC)
33.39%25.91%20.91%-7.90%-102.17%
Return on Tangible Assets
19.34%8.01%8.34%-12.69%-107.94%
Earnings Yield
13.25%6.76%32.29%-38.47%-35.26%
Efficiency Ratios
Receivables Turnover
 2.37 2.69 2.03 3.94 3.76
Payables Turnover
 41.43 8.80 20.32 8.42 8.52
Inventory Turnover
 98.10 150.38 99.55 62.78 57.70
Fixed Asset Turnover
 2.48 2.55 1.48 0.92 0.74
Asset Turnover
 0.88 0.95 0.73 0.62 0.51
Working Capital Turnover Ratio
 1.96 3.29 5.21 6.55 2.75
Cash Conversion Cycle
 148.68 96.66 165.22 54.99 60.55
Days of Sales Outstanding
 153.76 135.71 179.52 92.52 97.06
Days of Inventory Outstanding
 3.72 2.43 3.67 5.81 6.33
Days of Payables Outstanding
 8.81 41.47 17.96 43.35 42.84
Operating Cycle
 157.49 138.13 183.18 98.34 103.39
Cash Flow Ratios
Operating Cash Flow Per Share
 40.70 39.00 4.54 0.29 11.97
Free Cash Flow Per Share
 39.90 38.61 4.09 -1.87 8.51
CapEx Per Share
 0.79 0.40 0.45 2.15 3.46
Free Cash Flow to Operating Cash Flow
 0.98 0.99 0.90 -6.56 0.71
Dividend Paid and CapEx Coverage Ratio
 4.87 3.23 2.65 0.09 0.77
Capital Expenditure Coverage Ratio
 51.29 98.23 10.05 0.13 3.46
Operating Cash Flow Coverage Ratio
 0.81 0.71 0.07 <0.01 0.19
Operating Cash Flow to Sales Ratio
 0.33 0.28 0.05 <0.01 0.23
Free Cash Flow Yield
20.15%23.45%12.90%-6.92%2.99%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 7.54 14.79 3.10 -2.60 -2.84
Price-to-Sales (P/S) Ratio
 1.61 1.20 0.34 0.48 5.49
Price-to-Book (P/B) Ratio
 3.44 3.18 1.10 1.94 12.57
Price-to-Free Cash Flow (P/FCF) Ratio
 4.96 4.26 7.75 -14.44 33.48
Price-to-Operating Cash Flow Ratio
 4.86 4.22 6.98 94.73 23.80
Price-to-Earnings Growth (PEG) Ratio
 0.04 1.68 -0.02 0.03 <0.01
Price-to-Fair Value
 3.44 3.18 1.10 1.94 12.57
Enterprise Value Multiple
 3.91 4.22 3.08 -25.57 -3.65
Enterprise Value
 1.50B 1.21B 458.34M 372.78M 1.44B
EV to EBITDA
 3.91 4.22 3.08 -25.57 -3.65
EV to Sales
 1.77 1.39 0.95 1.51 6.56
EV to Free Cash Flow
 5.48 4.94 21.98 -45.24 39.96
EV to Operating Cash Flow
 5.37 4.89 19.80 296.69 28.41
Tangible Book Value Per Share
 68.81 61.04 33.81 9.42 19.43
Shareholders’ Equity Per Share
 57.39 51.79 28.69 13.94 22.68
Tax and Other Ratios
Effective Tax Rate
 0.21 0.26 0.13 0.10 -0.03
Revenue Per Share
 123.23 137.59 94.11 56.18 51.88
Net Income Per Share
 26.19 11.13 10.23 -10.39 -100.50
Tax Burden
 0.52 0.29 0.48 0.94 1.01
Interest Burden
 0.95 0.92 0.85 1.51 1.03
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.07 0.19 0.12 0.13 0.09
Stock-Based Compensation to Revenue
 0.01 0.13 0.03 0.01 <0.01
Income Quality
 1.04 1.38 0.24 -0.03 -0.12
Currency in USD